• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推动儿科艾滋病治疗议程:以科学、创新和合作。

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.

机构信息

ICAP at Columbia, Mailman School of Public Health, College of Physicians & Surgeons, Columbia University, New York, NY.

US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.

出版信息

J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S32-S39. doi: 10.1097/QAI.0000000000001747.

DOI:10.1097/QAI.0000000000001747
PMID:29994918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6044456/
Abstract

BACKGROUND

A number of well-described obstacles to the pediatric therapeutic agenda have resulted in substantial delays in the introduction of new medications, formulations, strategies, and approaches to treat infants, children, and adolescents living with HIV.

SETTING

Global landscape.

METHODS

The authors will provide a summary of current and emerging initiatives to accelerate the pediatric therapeutic agenda including illustrative case studies of innovations and scientific discovery in diagnosis and treatment of very young children with HIV infection.

RESULTS

The challenges posed by rapid physiologic and developmental changes that characterize the trajectory of childhood as well as the complex regulatory and fiscal milieu of HIV therapeutics have hampered pediatric HIV therapeutic research. Recent efforts to accelerate this agenda include prioritizing agents and formulations, defining dosing by weight bands, applying innovative study designs, synergizing work across research networks to achieve common goals, and the establishment of a global prioritized research agenda. A case study of initiatives to diagnose and effectively treat newborns and infants will illustrate the critical role of basic science research and novel approaches to study design and implementation that are informing global efforts to end AIDS.

CONCLUSIONS

A pediatric therapeutic agenda informed by basic science and achieved through innovation and global cooperation is essential to achieve an AIDS-free generation.

摘要

背景

许多描述详尽的儿科治疗障碍导致新药物、配方、策略和方法的引入出现了实质性的延迟,这些障碍旨在治疗感染艾滋病毒的婴儿、儿童和青少年。

地点

全球范围。

方法

作者将提供一份总结,内容是为加速儿科治疗议程而采取的当前和新兴举措,包括诊断和治疗 HIV 感染的非常年幼的儿童方面的创新和科学发现的说明性案例研究。

结果

儿童时期的轨迹特征是快速的生理和发育变化,以及 HIV 治疗的复杂监管和财政环境,这些都给儿科 HIV 治疗研究带来了挑战。最近为加速这一议程所做的努力包括优先考虑药物和配方、按体重带定义剂量、应用创新的研究设计、在研究网络之间协同工作以实现共同目标,以及制定全球优先研究议程。诊断和有效治疗新生儿和婴儿的举措案例研究将说明基础科学研究以及创新的研究设计和实施方法的关键作用,这些方法正在为全球消除艾滋病的努力提供信息。

结论

以基础科学为指导,通过创新和全球合作实现的儿科治疗议程,对于实现无艾滋病一代至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e7/6075894/f6779a2413f6/qai-78-s32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e7/6075894/f6779a2413f6/qai-78-s32-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e7/6075894/f6779a2413f6/qai-78-s32-g002.jpg

相似文献

1
Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.推动儿科艾滋病治疗议程:以科学、创新和合作。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S32-S39. doi: 10.1097/QAI.0000000000001747.
2
Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.儿科治疗扩大规模:全球计划未完成的议程。
J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S59-S65. doi: 10.1097/QAI.0000000000001333.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents.模拟建模和变形建模以支持国家和国际针对儿童和青少年的艾滋病毒政策。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S49-S57. doi: 10.1097/QAI.0000000000001749.
5
A Global Research Agenda for Pediatric HIV.儿科艾滋病全球研究议程。
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S10-S15. doi: 10.1097/QAI.0000000000001743.
6
A Global Research Agenda for Adolescents Living With HIV.全球艾滋病病毒感染者青少年研究议程
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 1(1):S16-S21. doi: 10.1097/QAI.0000000000001744.
7
Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens.全球儿童结核病、艾滋病和革兰氏阴性病原体感染中出现的耐药性问题。
Paediatr Int Child Health. 2021 Feb;41(1):65-75. doi: 10.1080/20469047.2020.1853350. Epub 2020 Dec 11.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries.缩短成人和儿科药物制剂之间长达十年的差距:基于中低收入国家艾滋病毒经验的新框架。
J Int AIDS Soc. 2018 Feb;21 Suppl 1(Suppl Suppl 1). doi: 10.1002/jia2.25049.
10
The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.全球儿科抗逆转录病毒市场:产品供应和利用情况分析表明,儿科配方制剂的开发和儿童艾滋病毒/艾滋病治疗面临挑战。
BMC Pediatr. 2010 Oct 17;10:74. doi: 10.1186/1471-2431-10-74.

引用本文的文献

1
Pediatric Antiretroviral Therapy Coverage and AIDS Deaths in the "Treat All" Era.儿科抗逆转录病毒治疗覆盖率和“全面治疗”时代的艾滋病死亡人数。
Pediatrics. 2023 Jun 1;151(6). doi: 10.1542/peds.2022-059013.
2
The promise of paediatric dolutegravir.儿科多替拉韦的前景。
J Int AIDS Soc. 2021 Jan;24(1):e25660. doi: 10.1002/jia2.25660.
3
Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life.出生后3周内开始抗逆转录病毒治疗11个月时的神经发育情况。

本文引用的文献

1
Implementation of an active case management network to identify HIV-positive infants and accelerate the initiation of antiretroviral therapy, Thailand 2015 to 2018.实施主动病例管理网络以发现 HIV 阳性婴儿并加快启动抗逆转录病毒治疗,泰国 2015 年至 2018 年。
J Int AIDS Soc. 2020 Feb;23(2):e25450. doi: 10.1002/jia2.25450.
2
Neglected Population, Neglected Right: Children Living with HIV and the Right to Science.被忽视的人群,被忽视的权利:感染艾滋病毒儿童与科学权
Health Hum Rights. 2017 Dec;19(2):169-181.
3
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations.
South Afr J HIV Med. 2019 Oct 30;20(1):1008. doi: 10.4102/sajhivmed.v20i1.1008. eCollection 2019.
优化研究以加速儿科抗逆转录病毒药物和配方的供应。
Clin Infect Dis. 2017 Jun 1;64(11):1597-1603. doi: 10.1093/cid/cix194.
4
Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.接受早期抗逆转录病毒治疗的HIV感染儿童在5岁时具有更大的皮质下灰质结构和更小的胼胝体。
Front Neuroanat. 2017 Nov 2;11:95. doi: 10.3389/fnana.2017.00095. eCollection 2017.
5
The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.南非早期婴儿HIV诊断项目中确证检测的价值:一项成本效益分析。
PLoS Med. 2017 Nov 21;14(11):e1002446. doi: 10.1371/journal.pmed.1002446. eCollection 2017 Nov.
6
Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.在一项多中心抗逆转录病毒临床试验中,感染艾滋病毒的非洲儿童的神经心理学表现。
AIDS. 2018 Jan 14;32(2):189-204. doi: 10.1097/QAD.0000000000001683.
7
Cultural Adaptation of an Evidence-Informed Psychosocial Intervention to Address the Needs of PHIV+ Youth in Thailand.一种基于证据的社会心理干预措施的文化调适,以满足泰国艾滋病毒阳性青年的需求。
Glob Soc Welf. 2017;4(4):209-218. doi: 10.1007/s40609-017-0100-x. Epub 2017 Jul 24.
8
A pilot evaluation of whole blood finger-prick sampling for point-of-care HIV viral load measurement: the UNICORN study.全血指刺采样用于即时 HIV 病毒载量测量的初步评估:UNICORN 研究。
Sci Rep. 2017 Oct 20;7(1):13658. doi: 10.1038/s41598-017-13287-2.
9
Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.接受抗逆转录病毒治疗的儿童中,A型小儿艾滋病毒感染未出现神经认知功能劣势。
J Int AIDS Soc. 2017 Oct;20(2). doi: 10.1002/jia2.25015.
10
Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.新生儿HIV感染的预防与治疗:世卫组织现有剂量建议的证据基础及实施考量
Expert Rev Clin Pharmacol. 2018 Jan;11(1):83-93. doi: 10.1080/17512433.2018.1393331. Epub 2017 Nov 8.